ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $231,558 | +31.7% | 471 | +4.4% | 0.01% | +33.3% |
Q2 2023 | $175,768 | +7.5% | 451 | +2.7% | 0.01% | 0.0% |
Q1 2023 | $163,563 | +0.4% | 439 | +2.1% | 0.01% | -14.3% |
Q4 2022 | $162,897 | +17.2% | 430 | +9.4% | 0.01% | +16.7% |
Q3 2022 | $139,000 | +8.6% | 393 | +16.6% | 0.01% | 0.0% |
Q2 2022 | $128,000 | +37.6% | 337 | +13.9% | 0.01% | +50.0% |
Q1 2022 | $93,000 | -30.6% | 296 | -22.7% | 0.00% | -20.0% |
Q4 2021 | $134,000 | +235.0% | 383 | +185.8% | 0.01% | +150.0% |
Q3 2021 | $40,000 | +135.3% | 134 | +143.6% | 0.00% | +100.0% |
Q2 2021 | $17,000 | 0.0% | 55 | -12.7% | 0.00% | 0.0% |
Q1 2021 | $17,000 | +142.9% | 63 | +162.5% | 0.00% | – |
Q4 2020 | $7,000 | +250.0% | 24 | +200.0% | 0.00% | – |
Q3 2020 | $2,000 | -75.0% | 8 | -86.9% | 0.00% | -100.0% |
Q1 2020 | $8,000 | – | 61 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |